Arkansas Cannabis
Market Intelligence Report

Arkansas's medical cannabis program, launched in 2019, has grown into one of the steadiest medical-only markets in the country. Sales reached a record $291.1 million in 2025, up roughly 5.5% from 2024 and marking the fourth consecutive annual record. Cumulative sales since launch have now surpassed $1.5 billion. The market operates under a tightly capped license structure — just 8 cultivation licenses and 40 dispensary licenses statewide — serving a patient base that reached 115,081 active medical marijuana cards as of June 2026.

Arkansas remains medical-only after two separate efforts to change that status both failed. Voters rejected a 2022 adult-use ballot measure (Issue 4), and in 2024 the Arkansas Supreme Court ruled that votes on Issue 3 — a measure to expand medical access that also contained a contingent adult-use legalization provision — could not be counted because its ballot title was misleading. No certified election result exists for Issue 3, and no new legalization measure is currently pending.

Arkansas's population of just over 3 million supports a medical cannabis patient base exceeding 115,000 — roughly 3.8% of the state's residents. (Official, Census ACS 2024)

Arkansas's medical cannabis program is regulated by the Alcoholic Beverage Control Division within the Department of Finance and Administration, with the Department of Health overseeing patient registration. License counts are fixed by statute at 8 cultivators and 40 dispensaries statewide — among the tightest caps of any medical-only program in this report set, with no current legislative effort to expand them.

Arkansas does not operate a dedicated tax-incentive or grant program for cannabis businesses; the fixed license-cap structure itself functions as the primary market-shaping policy lever.

Arkansas's cannabis supply chain runs through just 8 licensed cultivators supplying 40 dispensaries statewide — a notably concentrated structure compared to states with open or moratorium-affected licensing. Flower sales volume reached 79,223 pounds in 2025, up 4.8% from 75,598 pounds in 2024, indicating continued production scaling within the fixed cultivator base rather than new entrants.

Arkansas's patient base has grown steadily alongside sales, with both volume and dollar sales increasing in 2025 — a sign of expanding per-patient consumption as well as new patient registrations.

Arkansas's 40 dispensary licenses are distributed across the state's eight defined dispensary zones established at program launch, with concentrations in the Central Arkansas (Little Rock metro) and Northwest Arkansas (Fayetteville-Bentonville-Rogers) regions. The DFA does not publish a current county-by-county sales breakdown. (Not Available — county-level sales breakdown.)

With license counts fixed by statute at 8 cultivators and 40 dispensaries, Arkansas's cost-to-enter dynamics run almost entirely through the secondary market for existing licenses.

Vendor demand signal tracks which product and service categories Arkansas's small, stable operator base is actively sourcing this quarter.

Arkansas applies a 6.5% sales tax on dispensary purchases and a separate 4% privilege tax on cultivator-to-dispensary wholesale sales. Together, these two taxes generated $32.3 million in 2025 — growing in line with the market's record $291.1 million in sales.

Arkansas sits at the intersection of very different regional cannabis policies: one adult-use neighbor to the north, two medical-only neighbors to the south, and two states with no comprehensive program to the west and east.

Arkansas does not publish a consolidated statewide cannabis-industry employment figure. With only 8 cultivators and 40 dispensaries statewide, direct industry employment is likely modest relative to states with larger or open license counts, though no official total is available. (Not Available.)

Arkansas's medical marijuana program does not include a dedicated statewide social equity license track; the fixed 8-cultivator/40-dispensary cap structure has limited new-entrant opportunities of any kind since the program's 2019 launch. (Official.)

Arkansas does not publish an official illicit cannabis market size estimate. With cannabis remaining illegal for adult, non-patient use statewide, an unregulated market for non-patients likely exists alongside the licensed medical program, though no official dollar figure quantifies this. (Not Available.)

This report blends official DFA sales and tax data, Department of Health patient registry figures, certified election and court records, and reputable cannabis industry media.

This report compiles data from the Arkansas Department of Finance and Administration, the Arkansas Department of Health, certified state election and court records, federal demographic sources, and reputable cannabis industry media.